Hinge Health Inc. (NYSE:HNGE – Get Free Report) Chairman Gabriel M.I. Mecklenburg sold 50,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $65.54, for a total value of $3,277,000.00. Following the sale, the chairman directly owned 50,000 shares in the company, valued at approximately $3,277,000. The trade was a 50.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Gabriel M.I. Mecklenburg also recently made the following trade(s):
- On Monday, June 1st, Gabriel M.I. Mecklenburg sold 83,334 shares of Hinge Health stock. The stock was sold at an average price of $60.22, for a total transaction of $5,018,373.48.
- On Tuesday, May 26th, Gabriel M.I. Mecklenburg sold 83,333 shares of Hinge Health stock. The stock was sold at an average price of $53.79, for a total transaction of $4,482,482.07.
- On Wednesday, May 6th, Gabriel M.I. Mecklenburg sold 50,000 shares of Hinge Health stock. The shares were sold at an average price of $55.01, for a total transaction of $2,750,500.00.
- On Tuesday, April 21st, Gabriel M.I. Mecklenburg sold 33,333 shares of Hinge Health stock. The stock was sold at an average price of $45.05, for a total transaction of $1,501,651.65.
- On Wednesday, April 1st, Gabriel M.I. Mecklenburg sold 50,000 shares of Hinge Health stock. The shares were sold at an average price of $38.46, for a total value of $1,923,000.00.
Hinge Health Price Performance
Hinge Health stock opened at $63.48 on Monday. Hinge Health Inc. has a 1-year low of $30.08 and a 1-year high of $66.55. The business has a fifty day moving average price of $47.93 and a 200-day moving average price of $45.34. The stock has a market capitalization of $4.91 billion and a price-to-earnings ratio of -5.14.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on the stock. Piper Sandler reissued an “overweight” rating and set a $95.00 price target on shares of Hinge Health in a research report on Wednesday, May 6th. Citigroup reissued an “outperform” rating on shares of Hinge Health in a report on Wednesday, May 6th. Wells Fargo & Company boosted their target price on shares of Hinge Health from $68.00 to $80.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Zacks Research raised shares of Hinge Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Finally, Raymond James Financial reiterated an “outperform” rating and set a $70.00 price objective on shares of Hinge Health in a research note on Wednesday, May 6th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $67.53.
Get Our Latest Research Report on Hinge Health
Institutional Investors Weigh In On Hinge Health
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. BIT Capital GmbH grew its position in Hinge Health by 79.3% in the 4th quarter. BIT Capital GmbH now owns 3,316,101 shares of the company’s stock valued at $154,033,000 after acquiring an additional 1,466,577 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Hinge Health by 110.5% in the fourth quarter. Vanguard Group Inc. now owns 2,605,532 shares of the company’s stock valued at $121,027,000 after purchasing an additional 1,367,693 shares during the period. Tiger Global Management LLC grew its holdings in shares of Hinge Health by 227.1% in the fourth quarter. Tiger Global Management LLC now owns 1,805,751 shares of the company’s stock valued at $83,877,000 after purchasing an additional 1,253,743 shares in the last quarter. Marshall Wace LLP purchased a new stake in Hinge Health during the 4th quarter worth approximately $54,469,000. Finally, Millennium Management LLC increased its stake in Hinge Health by 225.0% during the 4th quarter. Millennium Management LLC now owns 1,479,642 shares of the company’s stock worth $68,729,000 after buying an additional 1,024,317 shares during the period.
Hinge Health News Summary
Here are the key news stories impacting Hinge Health this week:
- Positive Sentiment: Canaccord Genuity raised its price target on Hinge Health to $65 from $63 and reiterated a buy rating, reinforcing a constructive analyst view on the stock. Article Title
- Positive Sentiment: Other recent commentary also stayed upbeat, including technical coverage pointing to a “golden cross,” which can attract momentum investors. Article Title
- Positive Sentiment: Hinge Health’s last earnings report beat estimates, with revenue up 47.2% year over year, supporting the view that the business is still growing rapidly. Article Title
- Neutral Sentiment: One article highlighted Hinge Health as a promising mid-cap healthcare name, but it did not include a new catalyst beyond a generally favorable long-term investment case. Article Title
- Negative Sentiment: Chairman Gabriel M.I. Mecklenburg disclosed another large insider sale of 50,000 shares at $65.54, adding to a series of recent sales and potentially creating some overhang for sentiment. Article Title
About Hinge Health
Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.
Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.
Featured Stories
- Five stocks we like better than Hinge Health
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.
